MIRA INFORM REPORT

 

 

Report No. :

326207

Report Date :

12.06.2015

 

IDENTIFICATION DETAILS

 

Name :

MEDILAND ENTERPRISE CORPORATION

 

 

Registered Office :

Room B, 6th Floor, NO.185, Chung Shan N. Rd., Sec.2, Taipei

 

 

Country :

Taiwan

 

 

Date of Incorporation :

20.09.1984

 

 

Com. Reg. No.:

12520441

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacturing and sale of medical equipment

 

 

No of Employees :

About 220 Employees

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Taiwan

A2

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

B2

Moderate High Risk

 

C1

High Risk

C2

Very High Risk

D

 


 

TAIWAN ECONOMIC OVERVIEW

 

Taiwan has a dynamic capitalist economy with gradually decreasing government guidance of investment and foreign trade. Exports, led by electronics, machinery, and petrochemicals have provided the primary impetus for economic development. This heavy dependence on exports exposes the economy to fluctuations in world demand. Taiwan's diplomatic isolation, low birth rate, and rapidly aging population are other major long-term challenges. Free trade agreements have proliferated in East Asia over the past several years, and following the landmark Economic Cooperation Framework Agreement (ECFA) signed with China in June 2010, Taiwan in July 2013 signed a free trade deal with New Zealand—Taipei’s first-ever with a country with which it does not maintain diplomatic relations—and in November inked a trade pact with Singapore. However, negotiations on follow-on components of ECFA, including an agreement on trade in services, deals on trade in goods, and dispute resolution—have stalled. In early 2014, the government bowed to public demand for a new law governing the oversight of cross-Strait agreements, before any additional deals with China are implemented; the legislature has yet to vote on such legislation, leaving the future of ECFA up in the air as President MA enters his final full year in office. MA has portrayed ECFA as Taiwan’s key to greater participation in East Asia’s free trade networks. Taiwan's Total Fertility rate of just over one child per woman is among the lowest in the world, raising the prospect of future labor shortages, falling domestic demand, and declining tax revenues. Taiwan's population is aging quickly, with the number of people over 65 expected to account for 20% of the island's total population by 2025. The island runs a trade surplus, largely because of its surplus with China, and its foreign reserves are the world's fourth largest, behind those of China, Japan, and Russia. In 2006 China overtook the US to become Taiwan's second-largest source of imports after Japan. China is also the island's number one destination for foreign direct investment. Taiwan since 2009 has gradually loosened rules governing Chinese investment on the island, and has also secured greater market access for its investors in the mainland. In August 2012, the Taiwan Central Bank signed a memorandum of understanding on cross-Strait currency settlement with its Chinese counterpart. The MOU allows for the direct settlement of Chinese RMB and the New Taiwan dollar across the Strait, which has helped Taiwan develop into a local RMB hub. Closer economic links with the mainland bring greater opportunities for the Taiwan economy, but also pose new challenges as the island becomes more economically dependent on China at a time when political differences remain unresolved. During 2014, the press paid increasing attention to domestic economic issues while pushing aside the debates over trade liberalization that were a hallmark of MA’s tenure. The media focused on the divide between Taiwan’s “haves” and “have nots,” providing extensive coverage of public frustration with stagnant wages, skyrocketing housing prices, and the difficulty of finding entry-level jobs.

 

Source : CIA

 


Contact Points

 

Company Name:

Mediland Enterprise Corporation

Supplied Name:

MEDILAND ENTERPRISES CORPORATION

Trading Address:

No.75, Wenhua 1st Road, Leshan Village, Guishan Township, Taoyuan County, Taiwan

Supplied Address:

NO.75 WENHWA IST RD.KUEISHAN TOWNSHIP,TAOYUAN HSIEN COUNTRY 33382

Telephone Number:

+886-3-328-9140

Fax Number:

+886-3-397-2726

E-mail:

international@mediland.com.tw

Note: The exact name and address are as above.

 

Credit Summary

 

Credit Opinion:

Business connections are permissible.

 

 

Company Identification Details

 

Registered Name:

Mediland Enterprise Corporation

Registered Address:

Room B, 6th Floor, NO.185, Chung Shan N. Rd., Sec.2, Taipei Taiwan R.O.C.

Date of Foundation:

1984-9-20

Registration Number:

12520441

Registry:

Taipei City Government

Registered Capital:

NTD 100,000,000 (USD 3,230,000)

(As of 2015.6, 1 NTD = 0.0323 USD)

Paid-up Capital:

NTD 100,000,000 (USD 3,230,000)

Legal Representatives:

Chunsong Jiang

Legal Form:

Joint Stock Company

Principal Activities:

Manufacturing and sale of medical equipment, etc.

Staff:

About 220 Employees

Listed at Stock Exchange:

No

Date of Last Annual Return:

2014-9-29

 

 

History

 

Subject was incorporated on 1984-9-20 with registered number 12520441 as Joint Stock Company in Taiwan.

 

 

Corporate Structure

 

Factories

1

Name:

Linkou Factory

Address:

No.75, Wenhua 1st Road, Leshan Li, Guishan Dist., Taoyuan County, Taiwan

Date of Foundation:

1986-6-3

Date of Registration:

1987-5-25

Factory Registration Number:

99621527

Factory Manager:

Chunsong Jiang

Status:

In Production

Date of Last Annual Return:

2002-10-16

Major Products:

332 medical equipment and supplies

277 optical instrument and equipment

276 radiation and electronic medical equipment

2

Address:

6/F., No.75-2, Wenhua 1st Road, Leshan Li, Guishan Dist., Taoyuan County, Taiwan

Date of Registration:

2015-5-6

Factory Registration Number:

68000053

Factory Manager:

Zhijun Zhan

Status:

In production

Date of Last Annual Return:

2015-5-6

Major Products:

277 optical instrument and equipment

 

Major Related Company

Name

Mediland (Nanjing) Medical Equipment Co., Ltd.

Address

No.29, Qinhuai Road, Jiangning Economic and Technological Development Zone, Nanjing City, Jiangsu Province, China

Registration Number

320100400016914

Date of Registration

2002-6-25

Registered Capital:

CNY 1,500,000

Legal Representatives:

Yimin Jiang

 

 

Shareholders

 

Major Shareholders

 

Name

Subscription Shares

Ding Jia Investment Co., Ltd. (Literal Translation)

1,000,000         

 

Shareholder Information:

Registered Name:

Ding Jia Investment Co., Ltd. (Literal Translation)

Registered Address:

6th Floor-1, No.185, Sec 2, Zhongshan North Road, Zhongshan District, Taipei City, Taiwan

Date of Foundation:

1993-5-20

Registration Number:

84255651

Registry:

Taipei City Government

Registered Capital:

NTD 6,500,000 (USD 209,950)

(As of 2015.06, 1 NTD = 0.0323 USD)

Paid-up Capital:

NTD 6,500,000 (USD 209,950)

Legal Representatives:

Chunsong Jiang

Legal Form:

Joint Stock Company

Date of Last Annual Return:

2015-4-17

 

Management Information

 

Core Management

 

Directors

1

Name

Chunsong Jiang

Position

Board Chairman

2

Name

Chunsen Jiang

Position

Director

3

Name

Tianen Jiang

Position

Director

4

Name

Yimin Jiang

Position

Supervisor

 

Personnel Structure

 

Total Employees

About 220 Employees

 

 

Operation Information

 

Offices & Factories

 

 

Headquarters

Add

No.75, Wenhua 1st Road, Leshan Village, Guishan Township, Taoyuan County, Taiwan

 

Production Information

 

l  Subject is engaged in manufacturing of medical equipment, etc.  

l  Subject has two factories in Taoyuan County, Taiwan for production.

l  Subject obtained the certification of ISO 9001:2008.

 

Purchase Information

 

l  The registered activities of subject:

Business Code

Details

--

General import and export business

--

Sales of medical equipment

--

Sales, installation, repair of all kinds of telecommunication equipment (include wireless radio transceiver) and design, testing radio communications system

--

Installation of all kinds of telecommunications line engineering

--

As an agent assist in developing quoting, bidding and distributing about home and abroad company’s products (except future goods)

CF01011

Manufacturing of medical equipment

CE01030

Manufacturing of optical instrument

CA02990

Manufacturing of other metal product (hanging bracket, sterilizing pan)

CE01010

Manufacturing of general instrument

F108031

Wholesale of medical equipment

ZZ99999

Besides licensed business, all other business items those are not banned or restricted.

 

l  The components and raw material for production are mostly purchased in domestic market.

 

Sales Information

 

l  Subject is engaged in sale of medical equipment, etc.

l  Subject’s major products are surgical light, surgical table, pendant system, or integration system and accessory, etc.

l  Subject has own brand “Mediland”.

l  Subject’s sales regions include Taiwan, Mainland China, Japan, South Korea, India, Europe and America, etc.

l  Subject’s major customers are Steris Corporation, Exim America Corp. and American Hosp Scief Equip Co Del Peru SA, etc.

 

Import and export right:

Import right

Yes

Export right

Yes

 

 

Settlements

 

Purchase

 

1.     Domestic Purchase

Products

Raw material

Payment Terms

T/T, Cash, etc.

 

2.     Import

 

Subject has little import.

 

Sales

 

1.     Domestic Markets

Product

Medical equipment, etc.

Selling Terms

T/T, Cash, etc.

 

2.     Export

Product

Medical equipment, etc.

Selling Terms

L/C, T/T, etc.

 

Financial Information

 

Subject has no obligations to disclose its financial statements to the third party according to the relevant policy in Taiwan and the only source from which we can obtain the information is the subject itself.

Subject’s relevant staff declined to disclose its financials citing the grounds of company’s confidentiality; from other sources we could not obtain such information, either.

 

Bankers

 

Subject declined to disclose its bank details; from other source we could not obtain the relevant information, either.

 

Public Record

 

Mortgage

 

No chattel mortgage record of subject has been found within the recent 3 months.

 

Lawsuit

 

Up to date of reporting, no existing or latent litigation of the subject has been found.

 

 

Special Note

 

Interview Details

Name

Mr. Chen

Department

Sales Department

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 63.89

UK Pound

1

Rs. 98.89

Euro

1

Rs. 72.31

 

INFORMATION DETAILS

 

Analysis Done by :

KRN

 

 

Report Prepared by :

DPT

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.